Cite
HARVARD Citation
Loglio, A. et al. (2019). Lamivudine prophylaxis prevents hepatitis B virus reactivation in anti-HBc positive patients under rituximab for non-Hodgkin lymphoma. Digestive and liver disease. 51 (3), pp. 419-424. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Loglio, A. et al. (2019). Lamivudine prophylaxis prevents hepatitis B virus reactivation in anti-HBc positive patients under rituximab for non-Hodgkin lymphoma. Digestive and liver disease. 51 (3), pp. 419-424. [Online].